GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CardioGenics Holdings CGNH · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2015

Net income

−$1.9m

FY2014FY2015

Free cash flow

−$608,696

FY2014FY2015

Shareholders' equity

−$1.6m

FY2014FY2015

Income statement

Fiscal years

FY2015FY2014
Research and development$215,790$500,935
Operating income−$772,142−$973,506
Net income−$1.9m−$2.7m
Diluted earnings per share-0.02-0.04

Balance sheet

At each fiscal year end

FY2015FY2014
Total assets$231,932$269,930
Cash and short-term investments$49,875$70,676
Total liabilities$1.8m$1.4m
Debt$72,614$71,863
Shareholders' equity−$1.6m−$1.2m
Shares outstanding117m66m

Cash flow

Fiscal years

FY2015FY2014
Cash from operations−$606,639−$597,111
Capital spending−$2,057—
Free cash flow−$608,696−$597,111

Latest quarters

By quarter end

Jan 2016Oct 2015Jul 2015Apr 2015Jan 2015Oct 2014Jul 2014Apr 2014
Operating income−$201,096−$311,732−$99,905−$154,809−$205,696−$308,486−$197,456−$205,394
Net income−$125,292−$367,127−$611,490$123,123−$1.1m−$1.4m−$565,627−$339,751
Diluted earnings per share-0.00-0.00-0.010.00-0.01-0.02-0.01-0.01
Total assets$558,445$231,932$234,948$229,236$272,192$269,930$295,799$286,536
Cash and short-term investments$96,810$49,875$49,240$37,851$84,620$70,676$14,357$48,846
Debt$378,496$206,387$133,843$105,023$89,820$71,863$518,206$428,104
Shareholders' equity−$1.8m−$1.6m−$1.6m−$1.3m−$1.5m−$1.2m−$1.7m−$1.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-16.2%-17.2%-7.6%
Net income13.6%-1.1%0.1%

Valuation history

At each fiscal year end

FY2012
Price to sales0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%0%0%300%-28%2531%-50%67%300%43%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 22 Jun 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.